ASP Isotopes Inc. (ASPI) stock
ASPINasdaqMiscellaneous Chemical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3074% below fair value
$1.37−0.17 (-11.04%)
Close on Nov 17, 2026Market cap $210.03MP/E –Yield –
ASP Isotopes r&d expenses
Research and development expenses are spending on new products and technology.
ASP Isotopes's R&D Expenses for the twelve months ending Jun 30, 2026 was $22.04M, up 353.3% year over year. For fiscal 2025 it was $12.36M, up 293.7% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.36M | +293.7% |
| FY2024 | Dec 31, 2024 | $3.14M | +310.6% |
| FY2023 | Dec 31, 2023 | $764.58K | -40.0% |
| FY2022 | Dec 31, 2022 | $1.27M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.82M | +675.5% |
| Q1 FY2026 | Mar 31, 2026 | $5.26M | +244.0% |
| Q4 FY2025 | Dec 31, 2025 | $6.85M | +383.7% |
| Q3 FY2025 | Sep 30, 2025 | $3.10M | +199.5% |
| Q2 FY2025 | Jun 30, 2025 | $880.00K | +85.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.53M | +611.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.42M | +2073.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.03M | +332.5% |
| Q2 FY2024 | Jun 30, 2024 | $473.30K | +87.2% |
| Q1 FY2024 | Mar 31, 2024 | $215.13K | +3.8% |
| Q4 FY2023 | Dec 31, 2023 | $65.17K | -20.2% |
| Q3 FY2023 | Sep 30, 2023 | $239.20K | -67.9% |
| Q2 FY2023 | Jun 30, 2023 | $252.88K | +64.9% |
| Q1 FY2023 | Mar 31, 2023 | $207.33K | -29.2% |
| Q4 FY2022 | Dec 31, 2022 | $81.64K | – |
| Q3 FY2022 | Sep 30, 2022 | $745.46K | – |
| Q2 FY2022 | Jun 30, 2022 | $153.39K | – |
| Q1 FY2022 | Mar 31, 2022 | $293.05K | – |
See a number that looks wrong?